4.7 Editorial Material

New horizons for future research - Critical issues to consider for maximizing research excellence and impact

期刊

MOLECULAR METABOLISM
卷 14, 期 -, 页码 53-59

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.molmet.2018.05.007

关键词

Animal models; Sex and gender differences; Emerging technologies; Data reproducibility; Funding and training issues; Thematic functions of compounds or brain areas; G-Protein-coupled receptors in the brain

资金

  1. Medical Research Council [MR/N02589X/1] Funding Source: Medline
  2. NIDDK NIH HHS [R01 DK116004] Funding Source: Medline
  3. NIMH NIH HHS [R01 MH059911] Funding Source: Medline
  4. MRC [MR/N02589X/1] Funding Source: UKRI

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

Decoding perineuronal net glycan sulfation patterns in the Alzheimer's disease brain

Aric F. Logsdon, Kendra L. Francis, Nicole E. Richardson, Shannon J. Hu, Chelsea L. Faber, Bao Anh Phan, Vy Nguyen, Naly Setthavongsack, William A. Banks, Randy L. Woltjer, C. Dirk Keene, Caitlin S. Latimer, Michael W. Schwartz, Jarrad M. Scarlett, Kimberly M. Alonge

Summary: The study found that patients with AD-related dementia experience a re-coding of their PNN-associated CS-GAGs, correlating with the progression of pathology, accumulation of p-tau, and cognitive impairment. These sulfation changes can be detected prior to classical AD pathology, potentially playing a crucial role in the development of the disease.

ALZHEIMERS & DEMENTIA (2022)

Review Pharmacology & Pharmacy

Brain GLP-1 and the regulation of food intake: GLP-1 action in the brain and its implications for GLP-1 receptor agonists in obesity treatment

Stefan Trapp, Daniel Brierley

Summary: This review examines the similarities and differences between physiological systems regulated by gut-derived and neuronally produced GLP-1, discussing whether peripheral and central sources of GLP-1 are separate, linked, or redundant systems, as well as the heterogeneity or homogeneity of the brain GLP-1 system, and the implications for using GLP-1 receptor agonists as anti-obesity drugs.

BRITISH JOURNAL OF PHARMACOLOGY (2022)

Review Pharmacology & Pharmacy

Reappraising the role of the vagus nerve in GLP-1-mediated regulation of eating

Daniel I. Brierley, Guillaume de Lartigue

Summary: This review focuses on the evidence supporting the involvement of the vagus nerve in mediating the effects of peripherally and centrally produced GLP-1 on eating behavior and energy balance. Recent studies using genetic, viral, and transcriptomic approaches have provided insights into the anatomical and functional organization of GLP-1-mediated gut-brain signaling pathways, challenging traditional ideas and potentially impacting the development of pharmacological treatments for obesity.

BRITISH JOURNAL OF PHARMACOLOGY (2022)

Article Gastroenterology & Hepatology

LPS induces rapid increase in GDF15 levels in mice, rats, and humans but is not required for anorexia in mice

Anita R. Patel, Henriette Frikke-Schmidt, Olivier Bezy, Paul Sabatini, Nikolaj Rittig, Niels Jessen, Martin G. Myers, Randy J. Seeley

Summary: The study found that Lipopolysaccharide (LPS) can increase levels of GDF15 in mice, rats, and humans, but GDF15 is not necessary for inducing anorexia and weight loss in response to moderate systemic infection.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2022)

Review Medicine, Research & Experimental

Transcellular routes of blood-brain barrier disruption

Michelle A. Erickson, William A. Banks

Summary: Disruption of the blood-brain barrier (BBB) can occur through different mechanisms and pathways, resulting in different neurological insults. The importance of transcellular pathways in BBB disruption has been highlighted. Transcytotic mechanisms are less clearly linked to permeability compared to membrane spanning canaliculi and fenestrations. Cellular components involved in transcellular mechanisms of BBB disruption are being discovered and measured, adding to our classic knowledge based on ultrastructural studies.

EXPERIMENTAL BIOLOGY AND MEDICINE (2022)

Article Pharmacology & Pharmacy

Brain uptake and distribution patterns of 2-hydroxypropyl-ss-cyclodextrin after intrathecal and intranasal administration

William A. Banks, Pericles Calias, Kim M. Hansen, Kristin M. Bullock, Kory Engelke

Summary: This study evaluated the uptake and distribution of kleptose in the brain and spinal cord after intranasal and intrathecal delivery. The results showed that intrathecal delivery resulted in higher distribution in the brain compared to intranasal delivery.

JOURNAL OF PHARMACY AND PHARMACOLOGY (2022)

Article Medicine, Research & Experimental

Vertical sleeve gastrectomy induces enteroendocrine cell differentiation of intestinal stem cells through bile acid signaling

Ki-Suk Kim, Bailey Ce Peck, Yu-Han Hung, Kieran Koch-Laskowski, Landon Wood, Priya H. Dedhia, Jason R. Spence, Randy J. Seeley, Praveen Sethupathy, Darleen A. Sandoval

Summary: This study found that vertical sleeve gastrectomy (VSG) increases the number of hormone-secreting enteroendocrine cells (EECs) in the intestine through bile acid signaling, which drives intestinal stem cell fate towards EEC differentiation.

JCI INSIGHT (2022)

Review Endocrinology & Metabolism

Toward a consensus nomenclature for ghrelin, its non-acylated form, liver expressed antimicrobial peptide 2 and growth hormone secretagogue receptor

Mario Perello, Suzanne L. Dickson, Jeffrey M. Zigman, Lorenzo Leggio

Summary: The stomach-derived peptide ghrelin, discovered in 1999, is an endogenous agonist of the growth hormone secretagogue receptor (GHSR) and plays key roles in various physiological functions. Its non-acylated form, desacyl-ghrelin, has a less well-understood physiological role. To establish a consistent nomenclature, experts in the field have proposed using the terms ghrelin and desacyl-ghrelin for the hormones, GHSR for the receptor, and LEAP2 for a recently recognized GHSR antagonist/inverse agonist.

JOURNAL OF NEUROENDOCRINOLOGY (2023)

Article Physiology

Neither glucagon-like peptide 1 receptors nor GDNF family receptor a-like neurons are required for aversive or anorectic response to deoxynivalenol (vomitoxin)

Anita R. Patel, Henriette Frikke-Schmidt, Paul V. Sabatini, Alan C. Rupp, Darleen A. Sandoval, Martin G. Myers, Randy J. Seeley

Summary: Deoxynivalenol (DON), a mycotoxin contaminating grain, induces nausea, emesis, and anorexia. The study found that GLP-1 is not necessary for DON-induced effects on food intake and visceral illness. Additionally, the study showed that the calcium-sensing receptor (CaSR) on GFRAL neurons may play a role in DON signaling, but neither GLP-1 signaling nor GFRAL signaling and neurons are required for DON-induced visceral illness or anorexia.

AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2023)

Article Clinical Neurology

Engagement of the brain orexin system in activity-based anorexia behaviour in mice

Erik Schele, Iris Stoltenborg, Anders Xie, Fiona Peris-Sampedro, Roger A. H. Adan, Suzanne L. Dickson

Summary: This study aims to investigate the activation of orexin neurons during severe anorectic state and the potential of suvorexant, a dual orexin receptor antagonist, in reducing excessive physical activity. The findings indicate that a large population of orexin neurons are activated in the ABA mouse model and that peripheral administration of suvorexant decreases food anticipatory activity. Orexin may be a suitable target for treating hyperactivity in AN, and further research is recommended to examine the efficacy of suvorexant in aiding AN patients in controlling excessive activity.

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2023)

Review Medicine, Research & Experimental

Cellular senescence and the blood-brain barrier: Implications for aging and age-related diseases

Rachel C. Knopp, Michelle A. Erickson, Elizabeth M. Rhea, May J. Reed, William A. Banks

Summary: The blood-brain barrier (BBB) is an important interface that regulates communication between the brain and blood. It is comprised of brain endothelial cells and is surrounded by supportive brain cell types. Recent studies have shown that the BBB undergoes dysfunction during aging and in diseases, and cellular senescence, one of the hallmarks of aging, is believed to play a role in these changes. This review summarizes the known age-related changes at the BBB, evaluates the impact of cellular senescence in neurodegenerative diseases, discusses insights from in vitro and in vivo studies, and explores mechanisms by which cellular senescence affects BBB function.

EXPERIMENTAL BIOLOGY AND MEDICINE (2023)

Editorial Material Endocrinology & Metabolism

Weight versus weight-independent effects of Roux-en-Y gastric bypass on type 2 diabetes

Samuel Klein, Randy J. Seeley

Summary: Many individuals with obesity and type 2 diabetes experience diabetes remission after Roux-en-Y gastric bypass surgery, but there is disagreement regarding the underlying mechanisms. We present our perspective on conflicting datasets suggesting that the remission could be attributed solely to weight loss or weight loss-independent factors.

NATURE METABOLISM (2023)

Article Psychology, Biological

Ghrelin is related to lower brain reward activation during touch

D. M. Pfabigan, E. R. Frogner, E. Schele, P. M. Thorsby, B. S. Skalhegg, S. L. Dickson, U. Sailer

Summary: Variations in ghrelin concentrations may affect the processing of touch as a social reward in humans, with higher ghrelin concentrations associated with a lower reward value for touch.

PSYCHOPHYSIOLOGY (2023)

Article Endocrinology & Metabolism

The local GLP-1 system in the olfactory bulb is required for odor-evoked cephalic phase of insulin release in mice

Mireia Montaner, Jessica Denom, Wanqing Jiang, Christophe Magnan, Stefan Trapp, Hirac Gurden

Summary: The study investigates the role of the GLP-1/glucagon-like peptide-1 receptor (GLP-1R) system in the olfactory bulb (OB) in foraging behavior and odor-evoked Cephalic Phase Insulin Release (CPIR). The results demonstrate that GLP-1OB controls olfactory foraging and is required for odor-evoked CPIR.

MOLECULAR METABOLISM (2023)

Article Endocrinology & Metabolism

Identification of a regulatory pathway inhibiting adipogenesis via RSPO2

Hua Dong, Wenfei Sun, Yang Shen, Miroslav Balaz, Lucia Balazova, Lianggong Ding, Mona Loeffler, Bradford Hamilton, Nora Kloeting, Matthias Blueher, Heike Neubauer, Holger Klein, Christian Wolfrum

Summary: Dong and Sun et al. demonstrate the inhibitory role of adipogenesis regulatory cells in murine white adipose tissue through RSPO2. They show that RSPO2 regulates the maturation of early progenitor cells via Lgr4. This study highlights the importance of cellular crosstalk in adipogenesis and its impact on adipose tissue homeostasis.

NATURE METABOLISM (2022)

Article Endocrinology & Metabolism

Extracellular macrophage migration inhibitory factor (MIF) downregulates adipose hormone-sensitive lipase (HSL) and contributes to obesity

Liujun Chen, Lisha Li, Donghong Cui, Yiheng Huang, Haibin Tong, Haleh Zabihi, Shuxia Wang, Yadan Qi, Ted Lakowski, Lin Leng, Suixin Liu, Hong Wu, Lawrence H. Young, Richard Bucala, Dake Qi

Summary: Attenuation of adipose hormone sensitive lipase (HSL) may impair lipolysis and exacerbate obesity. Cytokine macrophage migration inhibitory factor (MIF) plays a role in regulating adipose HSL and adipocyte hypertrophy. Both intracellular and extracellular MIF have opposing effects on HSL, but extracellular action predominates to downregulate HSL and exacerbate obesity development during high-fat diet (HFD).

MOLECULAR METABOLISM (2024)

Article Endocrinology & Metabolism

GPSM1 in POMC neurons impairs brown adipose tissue thermogenesis and provokes diet-induced obesity

Mengyang Tang, Yi Zhang, Rong Zhang, Yuemei Zhang, Jiangfei Zheng, Daixi Wang, Xinyu Wang, Jing Yan, Cheng Hu

Summary: This study aimed to explore the role of GPSM1 in POMC neurons and the underlying mechanisms in metabolic homeostasis. Through various molecular, biochemical, immunofluorescent, immunohistochemical analyses, and cell culture studies, the study revealed the pathophysiological role of GPSM1 in POMC neurons and its regulation of POMC neuron activity.

MOLECULAR METABOLISM (2024)